NCT01356316View on ClinicalTrials.gov

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

March 31, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

AdimFlu-S Vaccine 2010-2011

Per ml contains following strains 30μg, A/California/7/2009 (H1N1), A/Perth/16/2009 (H3N2) and B/Brisbane/60/2008

Sponsors
All Listed Sponsors
lead

Adimmune Corporation

INDUSTRY

NCT01356316 - Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects | Biotech Hunter | Biotech Hunter